In mice, administration of the GBA2 inhibitor miglustat and disruption of the Gba2 gene elevate the glucosylceramide level in testis, spleen, and brain [4, 5] and impair spermatogenesis [9–11], resulting in male infertility [5, 12, 13]. Here, GBA2 is linked to male infertility.